Market Moves
Neuracle, maker of the world's first approved invasive BCI, files for a Shanghai STAR Market IPO with RMB 2.5B target raise
Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.